The ROE as of September 2024 (TTM) for SeaStar Medical Holding Corporation (ICU) is 323.08%

According to SeaStar Medical Holding Corporation’s latest financial reports and current stock price. The company's current ROE is 323.08%. This represents a change of 188.05% compared to the average of 112.16% of the last 4 quarters.

SeaStar Medical Holding Corporation (ICU) Historical ROE (quarterly & annually)

How has ICU ROE performed in the past?

The mean historical ROE of SeaStar Medical Holding Corporation over the last ten years is 119.80%. The current 323.08% ROE has changed 169.68% with respect to the historical average. Over the past ten years (40 quarters), ICU's ROE was at its highest in in the March 2024 quarter at 283.86%. The ROE was at its lowest in in the June 2021 quarter at -1.17%.

SeaStar Medical Holding Corporation (ICU) ROE by Quarter and Year

Discovering the peaks and valleys of SeaStar Medical Holding Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SeaStar Medical Holding Corporation (ICU) Average ROE

How has ICU ROE performed in the past?

The current ROE of SeaStar Medical Holding Corporation (ICU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

SeaStar Medical Holding Corporation (ICU) ROE vs. Peers

How is ICU’s ROE compared to its peers?

SeaStar Medical Holding Corporation’s ROE is greater than Virios Therapeutics, Inc. (-130.35%), greater than ZyVersa Therapeutics, Inc. (-172.51%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), greater than Revelation Biosciences, Inc. (-243.91%), greater than Quoin Pharmaceuticals, Ltd. (-112.11%), greater than Allarity Therapeutics, Inc. (-704.78%), less than Kiromic BioPharma, Inc. (337.72%), greater than Virax Biolabs Group Limited (-115.10%), greater than Biodexa Pharmaceuticals Plc (-141.90%), greater than Palisade Bio, Inc. (-124.86%), less than Unicycive Therapeutics, Inc. (294.74%), greater than Apexigen, Inc. (-606.56%), greater than Immix Biopharma, Inc. (-86.48%), less than CNS Pharmaceuticals, Inc. (428.91%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Navidea Biopharmaceuticals, Inc. (-63.06%),

Build a custom stock screener for SeaStar Medical Holding Corporation (ICU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SeaStar Medical Holding Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SeaStar Medical Holding Corporation (ICU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SeaStar Medical Holding Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.